Norway· NO-ID_E03BD3B9-5687-4F97-9B7F-0CFE5FF5267A
Praluent
A alirocumab product containing alirocumab, registered in Norway by Sanofi. The same ATC class is registered in 15 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Alirocumab is registered in 15 of 19 countries.
Countries holding a registration under ATC C10AX14 (alirocumab), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 10 of them publish a price we can compare per daily dose
Alirocumab · ATC C10AX14
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of alirocumab costs, country by country.
Normalised to the WHO defined daily dose (5.4 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Alirocumab · price per daily dose (5.4 mg)
USD · FX 28 Sept 2026
- CH Switzerland$16.93
The record
At a glance
FEST (Norway)- Active substance
- Alirocumab
- Manufacturer
- Sanofi
- Country
- Norway (NO)
- ATC code
- C10AX14
- ATC class
- Alirocumab
- Defined daily dose
- 5.4 mg, P
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
- no_merkevare_idID_E03BD3B9-5687-4F97-9B7F-0CFE5FF5267A
- no_varenummer2696642 x 1
- gtin5000283663928
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Alirocumab in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaPRALUENTSanofi Winthrop Industrie, Gentilly
- SpainPRALUENT 150 MG SOLUCION INYECTABLE EN JERINGA PRECARGADASanofi Winthrop Industrie
- SwedenPraluent 150 mg Injektionsvätska, lösning i förfylld injektionspennaSanofi Winthrop Industrie
- United KingdomPraluent 150mg/1ml solution for injection pre-filled pensSanofi
- IcelandPraluentSanofi Winthrop Industrie
- BelgiumPraluent 150 mgSanofi Winthrop Industrie
- SwitzerlandPraluent 150 mg, solution injectable en stylo prérempliSanofi-Aventis (Suisse) SA
- PolandPraluentSanofi Winthrop Industrie
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Praluent
- Liechtenstein · Praluent
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/756f9db2-02d6-4f5a-86e8-4ac75e7a9f48 GET /v1/drugs/756f9db2-02d6-4f5a-86e8-4ac75e7a9f48?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Injeksjonsvæske, oppløsning",
"source": "fest",
"status": "A",
"atc_name": "Alirokumab",
"merkevare_id": "ID_E03BD3B9-5687-4F97-9B7F-0CFE5FF5267A",
"name_form_strength": "Praluent inj, oppl 150 mg/penn",
"prescription_group": "C"
}See everything about alirocumab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.